PMOS Research Observatory

Explore PMOS Research

Search 20,749 PMOS papers published between 2015 and 2025. Filter by research topic, country, year range, or co-investigated condition to find where the field is active — and where the gaps are.

20,710 articles match

Total citations

289,983

Peak year

2025(3,021 articles)

Avg citations / article

14

Publications per year

All countries

Topics

All research areas

Endocrinology & Hormones12,696
Metabolic Health9,856
Fertility & Reproduction6,240
Epidemiology & Public Health3,114
Pharmacology & Treatment3,006
Diagnostics & Phenotyping2,317
Genetics & Genomics2,291
Mental Health & Psychology1,929

Countries

All countries

China3,806
United States2,435
India1,743
Iran1,194
Turkey922
United Kingdom754
Australia615
Italy475

Top journals

All filters

Fertility and Sterility584
Endocrine Abstracts510
Gynecological Endocrinology400
Frontiers in Endocrinology369
Figshare340
Journal of the Endocrine Society328
Human Reproduction275
Research Square (Research Square)270
PubMed258
The Journal of Clinical Endocrinology & Metabolism223

Top institutions

All filters

Monash University323
Tehran University of Medical Sciences234
Shanghai Jiao Tong University228
Shahid Beheshti University of Medical Sciences221
Peking University212
Shandong University177
Karolinska Institutet167
Peking University Third Hospital166
Monash Health165
University of Adelaide156

Where in the world is each topic being researched?

Toggle between Revealed Comparative Advantage (RCA), a specialisation index where values above 1.0 mean a country focuses on that topic more than average, and raw article counts.

HormonesMetabolicFertilityEpidemiol.PharmaDiagnos.GeneticsMentalNutritionMolecularInflamm.Cell BioLifestyleMicrobiomeDermatol.
China1.00.91.10.91.10.71.50.40.71.91.12.10.51.40.2
United States1.01.11.01.30.81.10.91.40.60.60.70.61.00.61.3
India0.90.90.90.90.91.91.11.11.70.80.70.61.21.21.9
Iran1.00.90.90.91.60.50.71.21.80.92.00.71.10.90.8
Turkey1.21.20.80.40.41.40.51.01.00.61.70.50.41.31.4
United Kingdom0.91.00.91.31.00.90.82.00.90.50.70.31.80.51.3
Australia0.81.10.91.91.10.80.62.10.70.20.10.54.00.40.5
Italy1.11.21.00.80.91.20.50.81.50.60.70.30.51.01.0
Egypt1.00.81.90.41.70.80.40.61.10.61.00.50.30.32.2
Poland1.31.40.50.60.40.80.61.20.80.61.20.41.11.71.6
Under-specialised
Specialised|RCA > 1 = country focuses on this topic more than average

Studies321340 of 20,710

All studies

Mogroside V restores glycolytic function via LDHA promoter demethylation independent of alternative splicing in PCOS granulosa cells.

2025The Journal of steroid biochemistry and molecular biology3 citationsDOI ↗
Cell Biology & Animal Models

Using non-invasive indicators to screen the PCOS population for liver disease - a single-centre study.

2025Endokrynologia Polska3 citationsDOI ↗
Diagnostics & PhenotypingEpidemiology & Public HealthMetabolic Health

Polycystic ovarian syndrome and long-term risk of acute myocardial infarction and ischaemic stroke.

2025European journal of preventive cardiology3 citationsDOI ↗
Epidemiology & Public HealthMetabolic Health

Association of insulin resistance with in vitro fertilization outcomes in women without polycystic ovarian syndrome: potential improvement with metformin treatment.

2025Human reproduction (Oxford, England)3 citationsDOI ↗
Fertility & ReproductionMetabolic HealthPharmacology & Treatment

Effects of letrozole combined with clomiphene in the treatment of polycystic ovary syndrome: a meta-analysis

2025BMC Women s Health3 citationsDOI ↗
Epidemiology & Public HealthFertility & ReproductionPharmacology & Treatment

Polycystic ovary syndrome: The role of granulosa cell proliferation and apoptosis in disease development

2025The Journal of Steroid Biochemistry and Molecular Biology3 citationsDOI ↗
Cell Biology & Animal ModelsMolecular Mechanisms

The Potential Role of Glucagon-Like Peptide-1 (GLP-1) Agonists for Polycystic Ovary Syndrome

2025Cureus3 citationsDOI ↗
Endocrinology & HormonesEpidemiology & Public HealthMetabolic Health

Prevalence and risk factors of polycystic ovary syndrome among reproductive-aged women

2025International Journal of Reproduction Contraception Obstetrics and Gynecology3 citationsDOI ↗
Dermatology & AestheticsDiagnostics & PhenotypingEpidemiology & Public Health

Hydroxychloroquine enhances insulin sensitivity and ameliorates abnormal lipid metabolism in obese women with polycystic ovary syndrome

2025BMC Endocrine Disorders3 citationsDOI ↗
Endocrinology & HormonesMetabolic HealthPharmacology & Treatment

Decoding the Relationship Between Polycystic Ovary Syndrome and Hormonal Dependencies of Anti-Müllerian Hormone and Other Markers

2025Biomedicines3 citationsDOI ↗
Dermatology & AestheticsDiagnostics & PhenotypingEndocrinology & Hormones

Fasting and postprandial oxytocin and incretin dynamics in women with polycystic ovary syndrome and healthy controls

2025European Journal of Endocrinology3 citationsDOI ↗
Molecular MechanismsNutrition & Diet